Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Journey Clinical

Explore full profile

Platform democratising patient access to psychedelic assisted therapy and providing self-employed psychotherapists necessary prescription access

New York City, United StatesFounded 2020Health Tech & Medtech
Valuation $0–100M Latest valuation · 2023
Revenue $1–10M Latest reported FY
Headcount 100–500 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Journey Clinical and the history behind them.

About Journey Clinical

Journey Clinical is a healthcare startup that operates in the mental health sector, specifically focusing on providing Ketamine-Assisted Psychotherapy (KAP) to patients suffering from conditions like depression, anxiety, and PTSD. KAP is a novel treatment approach that combines the use of the drug ketamine with psychotherapy, aiming to provide a more holistic and effective treatment for these conditions.

Read full description

The company's business model is patient-centered and collaborative, meaning that the decision to prescribe ketamine is made solely by the prescriber after a thorough medical consultation. This approach ensures that the treatment plan is personalized to meet the individual needs of each patient.

Journey Clinical serves as an in-house doctor and treatment partner, providing a one-stop-shop for all KAP needs. This means that they handle everything from the initial consultation to the prescription and administration of the drug, as well as the accompanying psychotherapy.

The company's revenue is likely generated through the fees charged for these services, although specific details are not publicly available.

The team behind Journey Clinical is composed of medical professionals with extensive experience in their respective fields, including MDs, PhDs, and licensed clinical social workers. This strong team composition suggests a high level of expertise and credibility in the services they provide.

In summary, Journey Clinical is a startup that operates in the mental health sector, providing innovative and personalized treatment plans for patients suffering from conditions like depression, anxiety, and PTSD.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2020
Headquarters
New York City, United States
Employees
102
Open positions
4
Dealroom signal
68.4/100
Industry
Health
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Mental Health, Tech for Medical Professionals, Tech for Patients, Psychedelic Drugs, Hard Tech
Business model
SaaS
Client focus
b2c, b2b

Latest news

Press, funding announcements and product moves mentioning Journey Clinical.

See all news

Funding history

5 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AEquity / VC Aug 2024 $0 FJ Labs
SERIES AEquity / VC Jan 2023 $8.5M $34M Fifty Years · Able Partners · Palo Santo Venture Fund · PsyMed Ventures
Showing the latest 2 of 5 recorded eventsBook a demo for the full funding history →

Financials

Revenue over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

YearRevenueGrowth
2026
2025
2024
2023
2022
2021
Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Journey Clinical website traffic

Latest recorded traffic for Journey Clinical is 60K monthly website visits, down 53.8% over the last three months. Journey Clinical's team declined 3.8% over the past year.

Latest monthly visits60K 3-month web change-53.8% 1-year team growth-3.8%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investors

21 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed8 investors entered at this stage

  • Neo Kuma Ventures
  • Fifty Years
  • Christina Sass
  • Palo Santo Venture Fund
  • PsyMed Ventures
  • Hans Gangeskar
  • Lionheart Ventures
  • Edvard Engesæth

Series A9 investors entered at this stage

Other known investors4 additional known investors

  • Audrey Capital
  • Calm Ventures
  • Colibri Equity Ventures
  • David Langer
Team profiled 13 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
4 countries with
team presence
🇺🇸 United States94.6%
🇵🇭 Philippines2.7%
🇨🇦 Canada1.4%
🇮🇩 Indonesia1.4%
4 countries shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Journey Clinical on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Journey Clinical’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.